Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial on the Role of Magnetic Resonance Imaging for Prostate Cancer Screening

NCT04803188 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial on the Role of Magnetic Resonance Imaging for Prostate Cancer Screening
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Unknown status
Start date
September 21, 2020
Completion date
September 30, 2022
Enrollment
710 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis)